Other ADAM10-dependent signalling pathways are also implicated in GBM development, including Notch signalling [20,21], where ADAM10 mediates ligand-dependent Notch receptor activation, suggesting a more complex role in tumour development. This evidence concerns the gene ADAM10 and glioblastoma.